Identifying optimal candidates for primary tumor surgery in patients with metastatic head and neck cancer

被引:1
作者
Liang, Qi-Wei [1 ,2 ]
Zhuang, Shuang-Hao [1 ]
Li, Sheng [1 ]
机构
[1] Longgang Ctr Hosp, Peoples Hosp Shenzhen 9, Dept Otorhinolaryngol, Shenzhen, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Thyroid Ctr Thyroid Surg, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN SURGERY | 2024年 / 11卷
关键词
metastasis; predictive models; nomogram; head and neck cancer; SEER; SQUAMOUS-CELL CARCINOMA; DISTANT METASTASIS; SURGICAL RESECTION; OPEN-LABEL; CHEMOTHERAPY; CETUXIMAB; RECURRENT; SURVIVAL; PEMBROLIZUMAB; KEYNOTE-048;
D O I
10.3389/fsurg.2024.1394809
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Primary tumor surgery (PTS) may enhance survival among part of patients with metastatic head and neck cancer (mHNC). Herein, a predictive model was needed to construct to identify who can gain benefit remarkably from tumor resection. Methods Data of patients with mHNC were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The best cut-off value of age were analyzed using the X-tile software. One-to-one PSM, Kaplan-Meier method, and log-rank test were performed for survival analysis.The independent factors determined using the multivariate Cox proportional hazard regression were used to construct the nomogram. Results A total of 1,614 patients diagnosed with mHNC were included; among them, 356 (22.0%) underwent a surgical procedure for the excision of the primary tumor. cancer-specific survival (CSS) was remarkably prolonged in the PTS group relative to the non-PTS group following PSM [Median:19 months vs. 9 months; hazard ratio (HR) 0.52, P < 0.001]. Patients with mHNC who were younger than 52 years old, had well-differentiated tumors, had T1 and N0 stages, and were married at the time of the study may have significantly benefited from PTS. In addition, we constructed a nomogram based on the factors that independently affect the CSS in multivariate Cox analysis. The nomogram showed excellent discrimination in both the training and validation sets (AUC: 0.732 and 0.738, respectively). Conclusion A practical predictive model was constructed to determine the appropriate patients with mHNC, who would benefit from surgical resection.
引用
收藏
页数:10
相关论文
共 32 条
  • [1] Survival Impact of Surgical Resection of Primary Tumor in Patients With Stage IV Colorectal Cancer
    Ahmed, Shahid
    Leis, Anne
    Fields, Anthony
    Chandra-Kanthan, Selliah
    Haider, Kamal
    Alvi, Riaz
    Reeder, Bruce
    Pahwa, Punam
    [J]. CANCER, 2014, 120 (05) : 683 - 691
  • [2] Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
  • [3] Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
    Austin, Peter C.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (25) : 3083 - 3107
  • [4] Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
    Burtness, Barbara
    Rischin, Danny
    Greil, Richard
    Soulieres, Denis
    Tahara, Makoto
    de Castro Jr, Gilberto
    Psyrri, Amanda
    Brana, Irene
    Baste, Neus
    Neupane, Prakash
    Bratland, Ase
    Fuereder, Thorsten
    Hughes, Brett G. M.
    Mesia, Ricard
    Ngamphaiboon, Nuttapong
    Rordorf, Tamara
    Wan Ishak, Wan Zamaniah
    Ge, Joy
    Swaby, Ramona F.
    Gumuscu, Burak
    Harrington, Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2321 - +
  • [5] Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
    Burtness, Barbara
    Harrington, Kevin J.
    Greil, Richard
    Soulieres, Denis
    Tahara, Makoto
    de Castro, Gilberto, Jr.
    Psyrri, Amanda
    Baste, Neus
    Neupane, Prakash
    Bratland, Ase
    Fuereder, Thorsten
    Hughes, Brett G. M.
    Mesia, Ricard
    Ngamphaiboon, Nuttapong
    Rordorf, Tamara
    Ishak, Wan Zamaniah Wan
    Hong, Ruey-Long
    Mendoza, Rene Gonzalez
    Roy, Ananya
    Zhang, Yayan
    Gumuscu, Burak
    Cheng, Jonathan D.
    Jin, Fan
    Rischin, Danny
    [J]. LANCET, 2019, 394 (10212) : 1915 - 1928
  • [6] X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp, RL
    Dolled-Filhart, M
    Rimm, DL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7252 - 7259
  • [7] Head and Neck Cancer
    Chow, Laura Q. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) : 60 - 72
  • [8] Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
    Cohen, Ezra E. W.
    Soulieres, Denis
    Le Tourneau, Christophe
    Dinis, Jose
    Licitra, Lisa
    Ahn, Myung-Ju
    Soria, Ainara
    Machiels, Jean-Pascal
    Mach, Nicolas
    Mehra, Ranee
    Burtness, Barbara
    Zhang, Pingye
    Cheng, Jonathan
    Swaby, Ramona F.
    Harrington, Kevin J.
    [J]. LANCET, 2019, 393 (10167) : 156 - 167
  • [9] Clinical implications of cancer self-seeding
    Comen, Elizabeth
    Norton, Larry
    Massague, Joan
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (06) : 369 - 377
  • [10] Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease
    Danna, EA
    Sinha, P
    Gilbert, M
    Clements, VK
    Pulaski, BA
    Ostrand-Rosenberg, S
    [J]. CANCER RESEARCH, 2004, 64 (06) : 2205 - 2211